{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:45:10Z","timestamp":1780058710399,"version":"3.54.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"The Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP160657"],"award-info":[{"award-number":["RP160657"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM123252"],"award-info":[{"award-number":["R01 GM123252"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"The Welch Foundation","doi-asserted-by":"publisher","award":["F-1390"],"award-info":[{"award-number":["F-1390"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.bioorg.2018.10.044","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T14:03:12Z","timestamp":1540303392000},"page":"290-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Design, synthesis and biological evaluation of fused naphthofuro[3,2-c] quinoline-6,7,12-triones and pyrano[3,2-c]quinoline-6,7,8,13-tetraones derivatives as ERK inhibitors with efficacy in BRAF-mutant melanoma"],"prefix":"10.1016","volume":"82","author":[{"given":"Ashraf A.","family":"Aly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essmat M.","family":"El-Sheref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momtaz E.M.","family":"Bakheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai A.E.","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Br\u00e4se","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Nieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyan K.","family":"Garvalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Dalby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer S.","family":"Kaoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.bioorg.2018.10.044_b0005","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1016\/0040-4020(84)85084-X","article-title":"A convenient synthesis of flindersine, atanine and their analogs","volume":"40","author":"Ramesh","year":"1984","journal-title":"Tetrahedron"},{"issue":"6","key":"10.1016\/j.bioorg.2018.10.044_b0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/14786410412331280078","article-title":"Tabouensinium chloride, a novel quaternary pyranoquinoline alkaloid from Araliopsis tabouensis","volume":"19","author":"Wabo","year":"2005","journal-title":"Nat. Prod. Res."},{"issue":"8","key":"10.1016\/j.bioorg.2018.10.044_b0015","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1021\/jm00128a042","article-title":"2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 12. 1,2-Dihydroquinolylmethyl analogues with high activity and specificity for bacterial dihydrofolate reductase","volume":"32","author":"Johnson","year":"1989","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2018.10.044_b0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1055\/s-2004-827153","article-title":"Photo-activated DNA binding and antimicrobial activities of furoquinoline and pyranoquinolone alkaloids from rutaceae","volume":"70","author":"Hanawa","year":"2004","journal-title":"Planta Med."},{"issue":"24","key":"10.1016\/j.bioorg.2018.10.044_b0025","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1016\/S0960-894X(97)10165-2","article-title":"Friedlander reaction on 2-amino-3-cyano-4H-pyrans: synthesis of derivatives of 4H-pyran[2,3-b]quinoline, new tacrine analogs","volume":"7","author":"Martinez-Grau","year":"1997","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2018.10.044_b0030","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/0006-2952(92)90387-X","article-title":"MY-1250, a major metabolite of the anti-allergic drug repirinast, induces phosphorylation of a 78-kDa protein in rat mast cells","volume":"44","author":"Yamada","year":"1992","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.bioorg.2018.10.044_b0035","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1021\/np070186g","article-title":"New Phenylpropenoids, Bis(1-phenylethyl)phenols, Bisquinolinone Alkaloid, and Anti-inflammatory Constituents from Zanthoxylum integrifoliolum","volume":"70","author":"Chen","year":"2007","journal-title":"J. Nat. Prod."},{"issue":"25","key":"10.1016\/j.bioorg.2018.10.044_b0040","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1016\/j.tetlet.2013.04.022","article-title":"ZnCl2-catalyzed three-component domino reactions for the synthesis of pyrano[3,2-c]quinolin-5(6H)-ones","volume":"54","author":"Gunasekaran","year":"2013","journal-title":"Tetrahedron Lett."},{"issue":"8","key":"10.1016\/j.bioorg.2018.10.044_b0045","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1021\/jm701499n","article-title":"Structural simplification of bioactive natural products with multicomponent synthesis. 2. antiproliferative and antitubulin activities of pyrano[3,2-c]pyridones and pyrano[3,2-c]quinolones","volume":"51","author":"Magedov","year":"2008","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2018.10.044_b0050","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.tetlet.2011.03.061","article-title":"A green, efficient, and rapid procedure for the synthesis of 2-amino-3-cyano-1,4,5,6-tetrahydropyrano[3,2-c]quinolin-5-one derivatives catalyzed by ammonium acetate","volume":"52","author":"Lei","year":"2011","journal-title":"Tetrahedron Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2018.10.044_b0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0223-5234(00)00129-X","article-title":"Naphthazarin derivatives (IV): synthesis, inhibition of DNA topoisomerase I and cytotoxicity of 2- or 6-acyl-5,8-dimethoxy-1, 4-naphthoquinones","volume":"35","author":"Song","year":"2000","journal-title":"Eur. J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2018.10.044_b0060","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1016\/j.bmc.2004.04.042","article-title":"Synthesis of 1-(omega-aminoalkyl)naphthoindolediones with antiproliferative properties","volume":"12","author":"Shchekotikhin","year":"2004","journal-title":"Bioorg. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2018.10.044_b0065","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1016\/j.bmc.2004.07.015","article-title":"Quinones as antimycobacterial agents","volume":"12","author":"Tran","year":"2004","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2018.10.044_b0070","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0968-0896(97)00133-8","article-title":"Synthesis and antiplatelet, antiinflammatory, and antiallergic activities of 2-substituted 3-chloro-1,4-naphthoquinone derivatives","volume":"5","author":"Lien","year":"1997","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2018.10.044_b0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bmc.2003.10.022","article-title":"Quantitative structure-activity relationship in aziridinyl-1,4-naphthoquinone antimalarials: study of theoretical correlations by the PM3 method","volume":"12","author":"dos Santos","year":"2004","journal-title":"Bioorg. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2018.10.044_b0080","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1016\/j.bmc.2005.04.041","article-title":"Studies on quinones. Part 39: synthesis and leishmanicidal activity of acylchloroquinones and hydroquinones","volume":"13","author":"Valderrama","year":"2005","journal-title":"Bioorg. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2018.10.044_b0085","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1021\/jm500754d","article-title":"Synthesis and structure-activity relationships of lapacho analogues. 2. Modification of the basic naphtho[2,3-b]furan-4,9-dione, redox activation, and suppression of human keratinocyte hyperproliferation by 8-hydroxynaphtho[2,3-b]thiophene-4,9-diones","volume":"57","author":"Bannwitz","year":"2014","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2018.10.044_b0090","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1021\/acs.jmedchem.6b00389","article-title":"Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an extracellular signal-regulated kinase 1\/2 (ERK1\/2) inhibitor in early clinical development","volume":"59","author":"Blake","year":"2016","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2018.10.044_b0095","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/2159-8290.CD-17-1119","article-title":"First-in-class ERK1\/2 inhibitor Ulixertinib (BVD-523) in patients with MAPK mutant advanced solid tumors: results of a phase i dose-escalation and expansion study","volume":"8","author":"Sullivan","year":"2018","journal-title":"Cancer Discov."},{"issue":"7675","key":"10.1016\/j.bioorg.2018.10.044_b0100","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature24037","article-title":"Cancer drug addiction is relayed by an ERK2-dependent phenotype switch","volume":"550","author":"Kong","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bioorg.2018.10.044_b0105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ccell.2014.11.018","article-title":"Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF\/MEK cotargeting but result in melanoma drug addiction","volume":"27","author":"Moriceau","year":"2015","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.bioorg.2018.10.044_b0110","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/2159-8290.CD-13-0070","article-title":"Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors","volume":"3","author":"Morris","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2018.10.044_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.12.001","article-title":"The ERK cascade inhibitors: towards overcoming resistance","volume":"25","author":"Maik-Rachline","year":"2016","journal-title":"Drug Resist. Updat."},{"issue":"11","key":"10.1016\/j.bioorg.2018.10.044_b0120","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1535-7163.MCT-17-0456","article-title":"Targeting the MAPK signaling pathway in cancer: promising preclinical activity with the novel selective ERK1\/2 inhibitor BVD-523 (Ulixertinib)","volume":"16","author":"Germann","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.bioorg.2018.10.044_b0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1515\/HC.2001.7.6.541","article-title":"Novel heterocycles from creatinine","volume":"7","author":"Mourad","year":"2001","journal-title":"Heterocycl. Commun."},{"issue":"3","key":"10.1016\/j.bioorg.2018.10.044_b0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ardp.200300802","article-title":"Novel reaction products from thiobarbituric Acid of biological interest","volume":"337","author":"Aly","year":"2004","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2018.10.044_b0135","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3184\/030823409X12561978806846","article-title":"NMR study of the naphtho-1,3-dithioles formed from carbamodithioates and 2,3-dichloro-1,4-naphthoquinone","volume":"11","author":"Aly","year":"2009","journal-title":"J. Chem. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2018.10.044_b0140","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/17415993.2017.1278762","article-title":"Oxidation-reduction and heterocyclization of the reactions of alkanedithiols with \u03c0-deficient compounds","volume":"38","author":"Aly","year":"2017","journal-title":"J. Sulf. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2018.10.044_b0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11696-017-0269-6","article-title":"Synthesis of pyrano[3,2-c]quinoline-4-carboxylates and 2-(4-oxo-1,4-dihydroquinolin-3-yl)fumarates","volume":"72","author":"El-Sheref","year":"2018","journal-title":"Chem. Pap."},{"issue":"3","key":"10.1016\/j.bioorg.2018.10.044_b0150","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00706-017-2078-6","article-title":"Synthesis of spiro[indoline-3,4'-pyrano[3,2-c]quinolone]-3'-carbonitriles","volume":"149","author":"Aly","year":"2018","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.bioorg.2018.10.044_b0155","article-title":"One-pot synthesis of 2,3-bis-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)succinates and arylmethylene-bis-3,3'-quinoline-2-ones","author":"Aly","year":"2018","journal-title":"Chem. Pap."},{"key":"10.1016\/j.bioorg.2018.10.044_b0160","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bioorg.2018.09.017","article-title":"Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies","volume":"81","author":"Aly","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2018.10.044_b0165","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/bi200202y","article-title":"Activated ERK2 is a monomer in vitro with or without divalent cations and when complexed to the cytoplasmic scaffold PEA-15","volume":"50","author":"Kaoud","year":"2011","journal-title":"Biochemistry"},{"issue":"44","key":"10.1016\/j.bioorg.2018.10.044_b0170","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1021\/bi201103b","article-title":"Examining docking interactions on ERK2 with modular peptide substrates","volume":"50","author":"Lee","year":"2011","journal-title":"Biochemistry"},{"issue":"31","key":"10.1016\/j.bioorg.2018.10.044_b0175","doi-asserted-by":"crossref","first-page":"E6287","DOI":"10.1073\/pnas.1702973114","article-title":"Local destabilization, rigid body, and fuzzy docking facilitate the phosphorylation of the transcription factor Ets-1 by the mitogen-activated protein kinase ERK2","volume":"114","author":"Piserchio","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bioorg.2018.10.044_b0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1021\/ml500198b","article-title":"Quantification of a pharmacodynamic ERK end point in melanoma cell lysates: toward personalized precision medicine","volume":"6","author":"Warthaka","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"issue":"7315","key":"10.1016\/j.bioorg.2018.10.044_b0185","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature09454","article-title":"Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma","volume":"467","author":"Bollag","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2018.10.044_b0190","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1479-5876-10-15","article-title":"Specifically targeting ERK1 or ERK2 kills melanoma cells","volume":"10","author":"Qin","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioorg.2018.10.044_b0195","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1476-4598-13-194","article-title":"Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanoma","volume":"13","author":"Wong","year":"2014","journal-title":"Mol. Cancer"},{"issue":"16","key":"10.1016\/j.bioorg.2018.10.044_b0200","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2018.10.044_b0205","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.bmcl.2014.04.068","article-title":"Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2","volume":"24","author":"Blake","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.bioorg.2018.10.044_b0210","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1023\/A:1020444330011","article-title":"Rate-limited steps of human oral absorption and QSAR studies","volume":"19","author":"Zhao","year":"2002","journal-title":"Pharm. Res."},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2018.10.044_b0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.bioorg.2018.10.044_b0220","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/jm00241a017","article-title":"4-hydroxy-3-nitro-2-quinolones and related compounds as inhibitors of allergic reactions","volume":"18","author":"Buckle","year":"1975","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2018.10.044_b0225","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1080\/00397918808082369","article-title":"One-pot synthesis of 7-[1,2-dihydro-4-hydroxy-1-methyl\/phenyl-2-oxo-3-quinolinyl]-5,7-dihydro-5-methyl\/phenyl-6H-[1]benzopyrano[3,2-c]quinolin-6-ones","volume":"18","author":"Rao","year":"1988","journal-title":"Synth. Commun."},{"issue":"5","key":"10.1016\/j.bioorg.2018.10.044_b0230","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-827X(99)00030-0","article-title":"The \u201cpyrono route\u201d to 4-hydroxy-2-quinolones and 4-hydroxy-2-pyridones","volume":"54","author":"Kappe","year":"1999","journal-title":"Farmaco"},{"issue":"32","key":"10.1016\/j.bioorg.2018.10.044_b0235","doi-asserted-by":"crossref","first-page":"9187","DOI":"10.1021\/bi700206u","article-title":"The anti-apoptotic protein PEA-15 is a tight binding inhibitor of ERK1 and ERK2, which blocks docking interactions at the D-recruitment site","volume":"46","author":"Callaway","year":"2007","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.bioorg.2018.10.044_b0240","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/pmic.201000565","article-title":"193-nm photodissociation of singly and multiply charged peptide anions for acidic proteome characterization","volume":"11","author":"Madsen","year":"2011","journal-title":"Proteomics"},{"issue":"6","key":"10.1016\/j.bioorg.2018.10.044_b0245","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1021\/jp1073522","article-title":"Understanding the specificity of a docking interaction between JNK1 and the scaffolding protein JIP1","volume":"115","author":"Yan","year":"2011","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.bioorg.2018.10.044_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2004.09.039","article-title":"Following in vitro activation of mitogen-activated protein kinases by mass spectrometry and tryptic peptide analysis: purifying fully activated p38 mitogen-activated protein kinase alpha","volume":"336","author":"Szafranska","year":"2005","journal-title":"Anal. Biochem."},{"issue":"11","key":"10.1016\/j.bioorg.2018.10.044_b0255","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1021\/cb300261e","article-title":"Manipulating JNK signaling with (\u2013)-zuonin A","volume":"7","author":"Kaoud","year":"2012","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2018.10.044_b0260","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.biophys.29.1.291","article-title":"Comparative protein structure modeling of genes and genomes","volume":"29","author":"Mart\u00ed-Renom","year":"2000","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"issue":"Web Server issue","key":"10.1016\/j.bioorg.2018.10.044_b0265","doi-asserted-by":"crossref","first-page":"W368","DOI":"10.1093\/nar\/gki464","article-title":"H++: a server for estimating pK(a)s and adding missing hydrogens to macromolecules","volume":"33","author":"Gordon","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.bioorg.2018.10.044_b0270","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein-ligand docking and virtual drug screening with the AutoDock suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat. Protocols"},{"issue":"22","key":"10.1016\/j.bioorg.2018.10.044_b0275","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges","volume":"36","author":"Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2018.10.044_b0280","unstructured":"SZYBKI, OpenEye Scientific Software, Santa Fe, NM, USA, 2016."},{"issue":"Pt 1","key":"10.1016\/j.bioorg.2018.10.044_b0285","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr. A"},{"issue":"1","key":"10.1016\/j.bioorg.2018.10.044_b0290","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"SHELXT - Integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr., Sect. A: Found. Adv."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T12:41:54Z","timestamp":1565268114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818309970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":58,"alternative-id":["S0045206818309970"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.044","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of fused naphthofuro[3,2-c] quinoline-6,7,12-triones and pyrano[3,2-c]quinoline-6,7,8,13-tetraones derivatives as ERK inhibitors with efficacy in BRAF-mutant melanoma","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}